Antithrombotics in vascular disease and renal dysfunction

Journal of the American College of Cardiology

This analysis evaluated whether the benefits of rivaroxaban 2.5 mg bd plus aspirin, comparedwith aspirin alone, are maintained in vascular patients who also have renal dysfunction.

Fracassi F, Crea F, et al.

Volume 73, Issue 18, May 2019

This study examined the prevalence,morphological features, and significance ofhealed plaques at the culprit site in patients withacute coronary syndromes usingoptical coherence tomography.

Risk/Benefit Tradeoff of Antithrombotic Therapy in Patients With Atrial Fibrillation Early and Late ...

Patients with Atrial fibrillation (AF) presenting with acute coronary syndrome (ACS) pose a great challenge in their management of antithrombotic and anti-platelet combination.

PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition and Risk of Venous Thromboembolism

Relationship of cholesterol and risk of venous thromboembolism(VTE) is uncertain with Mendelian randomization study suggesting a possible link between elevated LDL-C and VTE.